In vitro studies, AMF suppresses cell viability, invasion and migration of different types of cancers, including glioblastoma (Hsu et al., 2019) and HCC (Lee et al., 2018b) through inhibiting NF-κB activation and NF-κB-mediated downstream gene expression. Here, NFKB1 is linked to hepatocellular carcinoma.